Crypto Briefing·
Senators press HHS on prediction markets tied to drug trials
The rise of prediction markets in drug trials could undermine trial integrity, public trust, and ethical standards in medical research.
More news
- TokenPostMorgan Stanley Finds Measurable AI Gains at 44% of S&P 500 Firms
- TokenPostPeter Schiff Puts Bitcoin’s Cycle-Low Estimate Near $59,517
- TokenPostHesai Projects Q4 Net Revenue of RMB 1.1 Billion to RMB 1.15 Billion
- Crypto BriefingHIVE Digital Technologies signs $600 million in AI cloud contracts
- TokenPostLiquidia Sets 2028 PH-ILD Goal, 2029 L606 NDA Submission Target
- TokenPostOura to Acquire Counsel Health in $625 Million Cash Deal